SOFTBANK GROUP CORP.

Bank

Position in ABCL — AbCellera Biologics Inc.

CIK 1065521 TOKYO, M0

Position in ABCL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,709,513

+$1,504,902 QoQ

Shares Held

345,161

0.0% QoQ

Ownership

0.113%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#32

of 150 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SOFTBANK GROUP CORP. holds $71,633,769 across 4 Biotechnology names. ABCL ranks #4 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RXRX	Recursion Pharmaceuticals, Inc.	13,636,515	$50,046,010
2	NMRA	Neumora Therapeutics, Inc.	6,090,301	$10,353,511
3	SEER	Seer, Inc.	5,135,383	$8,524,735
4	ABCL	AbCellera Biologics Inc. This page	345,161	$2,709,513

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,709,513	345,161	0.0%	Shares	Defined	2026-08-14
2026-03-31	$1,204,611	345,161	0.0%	Shares	Defined	2026-05-15
2025-12-31	$1,180,450	345,161	—	Shares	Defined	2026-02-17
No filing history on record for this holder in this stock.